Deliver eConsent to sites and study participants around the globe with confidence
In 2017, Novartis decided to implement eConsent in order to improve the patient experience. After learning lessons during their pilot program, Novartis is now implementing the technology together with sites, and while most companies are still talking about becoming patient-centric, Novartis has gone ahead and done it.
Deliver eConsent to sites and study participants around the globe with confidence
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.